Authors:
Morgan, RJ
Synold, T
Carr, BI
Doroshow, JH
Womack, EP
Shibata, S
Somlo, G
Raschko, J
Leong, L
McNamara, M
Chow, W
Tetef, M
Margolin, K
Akman, S
Longmate, J
Citation: Rj. Morgan et al., Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy, CANC CHEMOT, 47(4), 2001, pp. 327-332
Authors:
Somlo, G
Doroshow, JH
Synold, T
Longmate, J
Reardon, D
Chow, W
Forman, SJ
Leong, LA
Margolin, KA
Morgan, RJ
Raschko, JW
Shibata, SI
Tetef, ML
Yen, Y
Kogut, N
Schriber, J
Alvarnas, J
Citation: G. Somlo et al., High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome, BR J CANC, 84(12), 2001, pp. 1591-1598
Authors:
Roberts, JD
Poplin, EA
Tombes, MB
Kyle, B
Spicer, DV
Grant, S
Synold, T
Moran, R
Citation: Jd. Roberts et al., Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation, CANC CHEMOT, 45(2), 2000, pp. 103-110